Cancer Gene Therapy

Lipid-based gene delivery appears effective against breast cancer

Published in Women's Health Weekly, August 21st, 2003

Targeted Genetics Corp. has presented data from its preclinical cancer program in a minisymposium titled "Enhanced Delivery Platforms for Gene Therapy" at the 94th Annual Meeting of the American Association for Cancer Research in Washington, D.C.

Studies were conducted using a targeted formulation of Targeted Genetics' proprietary synthetic, lipid-based gene delivery system called LPD-PEG. Data demonstrate that use of LPD-PEG, along with an additional targeting molecule, delivered systemically resulted in a significant reduction in tumor size and an increase in survival time when compared to non-targeted LPD-PEG in animal models of breast cancer.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2003-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry